Continued support for an interdisciplinary Pharmacology Graduate Training Program, currently in its 29th year, is proposed to prepare students for productive careers in disciplines where fundamental knowledge of quantitative and systems pharmacology is required. Alumni from this training program have gone on to academia, industry, regulatory science and consulting, to name a few of the variety of opportunities training in pharmacology provides. Our Predoctoral Training Program trains Pharmacology Graduate Group (PGG) students in classic principles of pharmacology including pharmacokinetics, dynamics, drug- receptor interactions as well as the newly emerging fields of proteomics and metabalomics. The PGG is supported by an interdepartmental group of 71 faculty from 20 departments in 4 Schools of the University of Pennsylvania. The Office of Biomedical Graduate Studies (BGS) ensures curricular development, quality control and uniform admission standards across all Graduate Groups, including PGG. Direct management of the Pharmacology Training Program is done by a five-person Advisory Committee that, in corrdination with the Executive Committee of the PGG, defines and reviews policy and selects trainees. Pharmacology Training Grant Faculty membership is governed by three criteria: (1) expertise in a relevant field of study, (2) significant contribution to training, and (3) extramura funding to support trainees. Admission of students to Graduate Programs is a tiered decision, first by the PGG, then by a BGS-wide admissions committee. Subsequent apppointment to the pharmacology training grant is decided by its Advisory Committee. Support for each trainee will encompass their first 12-24 months in thesis lab. Trainees must re-apply after the first 12 months and while most students are re- appointed for a second 12-month period, this intermediate evaluation enhances progress and productivity. Prior to appointment, students must successfully complete required courses in Cell and Molecular Biology, Fundamentals of Pharmacology and Medical pharmacology and Human physiology. Coursework extends over 1.5-2 years plus three lab rotations. All students will take a yearly course on the responsible conduct of scientific research. Students will also receive training through seminars, journal clubs, annual retreats, scientific meetings, oral and poster presentations, and social events that encourage interactions. Successful completion of a comprehensive Candidacy examination marks the start of independent research toward the dissertation. Thesis research is conducted under the supervision of a faculty advisor and is monitored by a thesis committee and the PGG Academic Review Committee. The dissertation defense takes place when the thesis advisor and committee concur that the body of work is complete. Based on the number of potential trainees, we request support for 12 predoctoral trainees/year for the next 5 years.

Public Health Relevance

This Predoctoral Pharmacology Training Program includes education and research opportunities to provide a multifaceted doctoral program that incorporates cutting-edge research and a curriculum that provides both depth and breadth in many areas of Pharmacology. It is designed to prepare students as leaders in pharmacological sciences in academia, government, and industry.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM008076-34
Application #
9480067
Study Section
NIGMS Initial Review Group (TWD)
Program Officer
Koduri, Sailaja
Project Start
1984-07-01
Project End
2019-06-30
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
34
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Pharmacology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Ojiaku, Christie A; Cao, Gaoyuan; Zhu, Wanqu et al. (2018) TGF-?1 Evokes Human Airway Smooth Muscle Cell Shortening and Hyperresponsiveness via Smad3. Am J Respir Cell Mol Biol 58:575-584
Jackson, Dan P; Ting, Jenhao H; Pozniak, Paul D et al. (2018) Identification and characterization of two novel alternatively spliced E2F1 transcripts in the rat CNS. Mol Cell Neurosci 92:1-11
Rhoades, Seth D; Nayak, Katrina; Zhang, Shirley L et al. (2018) Circadian- and Light-driven Metabolic Rhythms in Drosophila melanogaster. J Biol Rhythms 33:126-136
Reilly, Sean W; Puentes, Laura N; Wilson, Khadija et al. (2018) Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity. J Med Chem 61:5367-5379
Reilly, Sean W; Puentes, Laura N; Hsieh, Chia-Ju et al. (2018) Altering Nitrogen Heterocycles of AZD2461 Affords High Affinity Poly(ADP-ribose) Polymerase-1 Inhibitors with Decreased P-Glycoprotein Interactions. ACS Omega 3:9997-10001
Brynildsen, Julia K; Lee, Bridgin G; Perron, Isaac J et al. (2018) Activation of AMPK by metformin improves withdrawal signs precipitated by nicotine withdrawal. Proc Natl Acad Sci U S A 115:4282-4287
Malik, Dania M; Rhoades, Seth; Weljie, Aalim (2018) Extraction and Analysis of Pan-metabolome Polar Metabolites by Ultra Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS). Bio Protoc 8:
Allenby, Cheyenne; Falcone, Mary; Bernardo, Leah et al. (2018) Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimul 11:974-981
Reilly, Sean W; Puentes, Laura N; Schmitz, Alexander et al. (2018) Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant. Bioorg Chem 83:242-249
Henrich, Ian C; Young, Robert; Quick, Laura et al. (2018) USP6 Confers Sensitivity to IFN-Mediated Apoptosis through Modulation of TRAIL Signaling in Ewing Sarcoma. Mol Cancer Res 16:1834-1843

Showing the most recent 10 out of 124 publications